Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma

Ampullary adenocarcinoma is a rare gastrointestinal cancer associated with diverse outcomes due to clinical and pathological heterogeneity. Standardized methods to better prognosticate and inform therapeutic selection for ampullary adenocarcinoma are needed.